^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersBIOMARKER:
MET amplification + TP53 mutation + SMAD4 mutation + CTNNA1 mutation
i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase, TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1, HSMAD4, Mothers Against DPP Homolog 4, SMAD, Mothers Against DPP Homolog 4, Deleted In Pancreatic Carcinoma Locus 4, SMAD, Mothers Against DPP Homolog 4, Mothers Against Decapentaplegic, Drosophila, Homolog Of, 4, MADH4, MAD, Mothers Against Decapentaplegic Homolog 4, Mothers Against Decapentaplegic Homolog 4, MAD Homolog 4, SMAD4, SMAD Family Member 4, Deletion Target In Pancreatic Carcinoma 4, CTNNA1, Catenin Alpha 1, Renal Carcinoma Antigen NY-REN-13, Catenin Alpha-1, Alpha-E-Catenin, Catenin (Cadherin-Associated Protein), Alpha 1, 102kDa, Catenin (Cadherin-Associated Protein), Alpha 1 (102kD), Epididymis Secretory Sperm Binding Protein, Cadherin-Associated Protein, Alpha E-Catenin, CAP102, MDPT2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related biomarkers:
›
